Advanced Health Intelligence 과거 수익 실적

과거 기준 확인 0/6

Advanced Health Intelligence의 수입은 연평균 -25.2%의 비율로 감소해 온 반면, Healthcare Services 산업은 수입이 연평균 13%의 비율로 증가했습니다. 매출은 연평균 9.1%의 비율로 증가해 왔습니다.

주요 정보

-25.2%

수익 성장률

-10.7%

EPS 성장률

Healthcare Services 산업 성장	42.6%
매출 성장률	9.1%
자기자본 수익률	n/a
순이익	1,800.9%
최근 수익 업데이트	31 Dec 2023

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Advanced Health Intelligence 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

ASX:AHI 수익, 비용 및 수입 (AUD Millions )
날짜	수익	수익	G+A 비용
31 Dec 23	-1	-17	8
30 Sep 23	0	-15	7
30 Jun 23	1	-13	6
31 Mar 23	2	-11	7
31 Dec 22	2	-10	8
30 Sep 22	1	-15	8
30 Jun 22	0	-20	8
31 Mar 22	0	-22	6
31 Dec 21	0	-23	4
30 Sep 21	0	-19	4
30 Jun 21	1	-14	3
31 Mar 21	1	-11	3
31 Dec 20	1	-8	3
30 Sep 20	1	-7	3
30 Jun 20	0	-5	3
31 Mar 20	0	-5	2
31 Dec 19	0	-5	2
30 Sep 19	0	-5	2
30 Jun 19	0	-4	2
31 Mar 19	0	-4	2
31 Dec 18	0	-4	2
30 Sep 18	1	-9	2
30 Jun 18	2	-14	2
31 Mar 18	2	-14	2
31 Dec 17	2	-13	2
30 Sep 17	1	-8	2
30 Jun 17	0	-2	1
31 Mar 17	0	-2	1
31 Dec 16	0	-2	1
30 Sep 16	0	-2	1
30 Jun 16	0	-2	1
30 Jun 15	0	-1	1

양질의 수익: AHI 은(는) 현재 수익성이 없습니다.

이익 마진 증가: AHI 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: AHI 은(는) 수익성이 없으며 지난 5년 동안 연간 25.2% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 AHI 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: AHI 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare Services 업계( 13.3% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: AHI 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

Advanced Health Intelligence 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Recent updates

Advanced Health Intelligence Ltd, Annual General Meeting, Nov 29, 2024

Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.32

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.61

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

수익 및 비용 분석